Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Laboratorios Del Dr Esteve S a patents


Recent patent applications related to Laboratorios Del Dr Esteve S a. Laboratorios Del Dr Esteve S a is listed as an Agent/Assignee. Note: Laboratorios Del Dr Esteve S a may have other listings under different names/spellings. We're not affiliated with Laboratorios Del Dr Esteve S a, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Laboratorios Del Dr Esteve S a-related inventors


1-methylpyrazole-piperazine compounds having multimodal activity against pain

The present invention relates to 1-methylpyrazole-piperazine compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.... Laboratorios Del Dr Esteve S a

1,9-diazaspiro undecane compounds having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to 1,9-diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in... Laboratorios Del Dr Esteve S a

1,9-diazaspiro undecane compounds having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to 1,9-diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in... Laboratorios Del Dr Esteve S a

Tricyclic triazolic compounds

The present invention relates to new tricyclic triazolic compounds having a great affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicaments.... Laboratorios Del Dr Esteve S a

Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in... Laboratorios Del Dr Esteve S a

Methyl-1h-pyrazole alkylamine compounds having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to methyl-1 H-pyrazole alkylamine compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy,... Laboratorios Del Dr Esteve S a

Use of sigma receptor ligands in osteoarthritis

having pharmacological activity towards the sigma receptor, for use in the treatment or prevention of osteoarthritis and pain due to osteoarthritis.... Laboratorios Del Dr Esteve S a

Highly immunogenic hiv p24 sequences

The invention relates to peptides comprising part or all of a conserved element within a Center-of-Tree (COT) sequence derived from a family of polypeptides encoded by naturally occurring variants of HIV. The invention also relates to immunogenic compositions and vaccines comprising said peptides. The invention also relates to methods for... Laboratorios Del Dr Esteve S a

Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy

The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy.... Laboratorios Del Dr Esteve S a

Alkyl and aryl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain

The present invention relates to compounds of general formula (I) having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their... Laboratorios Del Dr Esteve S a

Adenoassociated virus vectors for the treatment of lysosomal storage disorders

The present invention provides new adenoassociated virus vectors and pharmaceutical compositions containing the same for the treatment of lysosomal storage disorders and specially, for the treatment of mucopolysaccharidoses Type IIIB.... Laboratorios Del Dr Esteve S a

Co-crystals of tramadol and coxibs

The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.... Laboratorios Del Dr Esteve S a

Piperidine compounds having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to piperidene compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular... Laboratorios Del Dr Esteve S a

Piperazine derivatives having multimodal activity against pain

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opioid receptor and more particularly to piperazine compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular... Laboratorios Del Dr Esteve S a

Oral pharmaceutical composition

The present invention relates to solid particles of a poorly soluble drug, pharmaceutical compositions comprising them and processes for their preparation. The compositions according to the present invention show an improved dissolution profile while being stable.... Laboratorios Del Dr Esteve S a

Co-crystals of tramadol and coxibs

The present invention relates to co-crystals of tramadol and co-crystal formers selected from NSAIDs/coxibs, processes for preparation of the same and their uses as medicaments or in pharmaceutical formulations, more particularly for the treatment of pain.... Laboratorios Del Dr Esteve S a








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Laboratorios Del Dr Esteve S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Laboratorios Del Dr Esteve S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###